梯瓦制药(TEVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TEVA 梯瓦制药

盘前交易 05-13 08:08:22 EDT

17.96

+1.03

+6.08%

盘前17.56

-0.40-2.23%

08:03 EDT

最高18.07	最低16.90	成交量1,943万
今开17.25	昨收16.93	日振幅6.91%
总市值205.99亿	流通市值205.09亿	总股本11.47亿
成交额3.46亿	换手率1.70%	流通股本11.42亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TEVA","market":"US","secType":"STK","nameCN":"梯瓦制药","latestPrice":17.96,"timestamp":1747080000000,"preClose":16.93,"halted":0,"volume":19428813,"hourTrading":{"tag":"盘前","latestPrice":17.56,"preClose":17.96,"latestTime":"08:03 EDT","volume":22155,"amount":389237.47296,"timestamp":1747137784401},"delay":0,"floatShares":1141911052,"shares":1146959855,"eps":-1.142604,"marketStatus":"盘前交易","change":1.03,"latestTime":"05-13 08:08:22 EDT","open":17.25,"high":18.07,"low":16.9,"amount":345615152.121522,"amplitude":0.069108,"askPrice":17.58,"askSize":100,"bidPrice":17.56,"bidSize":18,"shortable":3,"etf":0,"ttmEps":-1.142604,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747143000000},"marketStatusCode":1,"adr":0,"adrRate":1,"exchange":"NYSE","adjPreClose":17.96,"dividendRate":0.000056,"preHourTrading":{"tag":"盘前","latestPrice":17.56,"preClose":17.96,"latestTime":"08:03 EDT","volume":22155,"amount":389237.47296,"timestamp":1747137784401},"postHourTrading":{"tag":"盘后","latestPrice":17.8,"preClose":17.96,"latestTime":"19:55 EDT","volume":689163,"amount":12375326.5528,"timestamp":1747094144121},"volumeRatio":0.9305800379285257,"optionData":{"bulkOrders":[{"symbol":"TEVA","call":false,"expireDate":1750392000000,"strike":"15.0","timestamp":1747078293866,"price":0.14,"volume":7000,"amount":98000,"type":"+"},{"symbol":"TEVA","call":true,"expireDate":1750392000000,"strike":"18.0","timestamp":1747078293784,"price":0.87,"volume":7000,"amount":609000,"type":"-"}]},"impliedVol":0.4133,"impliedVolPercentile":0.2932},"requestUrl":"/m/hq/s/TEVA","defaultTab":"news","newsList":[{"id":"1132899114","title":"异动解读 | 梯瓦制药宣布大规模裁员计划，股价盘中大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132899114","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132899114?lang=zh_cn&edition=full","pubTime":"2025-05-10 01:14","pubTimestamp":1746810880,"startTime":"0","endTime":"0","summary":"梯瓦制药周五盘中股价大跌5.01%，跌幅显著。这一下跌主要源于公司最新宣布的大规模裁员计划。据悉，梯瓦制药于5月8日宣布，计划裁减约2900个工作岗位，占其员工总数的8%。此次裁员旨在削减7亿美元成本，以助力公司在2027年实现30%的运营利润率目标。目前，梯瓦制药的员工总数刚超过3.6万人。虽然此举可能有助于提高公司的长期盈利能力，但短期内可能会对公司运营和员工士气产生影响，这也是导致投资者信心受挫、股价下跌的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 梯瓦制药宣布大规模裁员计划，股价盘中大跌5.01%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TEVA"],"gpt_icon":0},{"id":"2534486777","title":"“华润系”再转让一家公司！罗氏重金在华布局生产基地，梯瓦裁撤数千名员工","url":"https://stock-news.laohu8.com/highlight/detail?id=2534486777","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534486777?lang=zh_cn&edition=full","pubTime":"2025-05-09 19:31","pubTimestamp":1746790285,"startTime":"0","endTime":"0","summary":"近日，上海联合产权交易所挂牌信息显示，华润三九挂牌转让三九（安国）现代中药开发有限公司49.8967%股权，转让底价162.15万元。在华润三九的财报中对这家公司的定位为联营企业。罗氏拟投资超20亿元在华新建生产基地5月8日，罗氏制药中国宣布投资20.4亿人民币，用于在上海新建生物制药生产基地。梯瓦宣布裁员2900人当地时间5月8日，梯瓦制药宣布拟削减约2900个工作岗位，占其员工总数的8%。目前，梯瓦制药的员工总数刚超过3.6万人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509201340a6d91635&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509201340a6d91635&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","TEVA","BK4566","BK4588","BK4007","BK4557","BK4585","BK4559","BK4596"],"gpt_icon":0},{"id":"2534157798","title":"B of A Securities：维持Teva Pharmaceutical Indus评级，由买入调整至买入评级, 目标价由20.00美元调整至22.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534157798","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534157798?lang=zh_cn&edition=full","pubTime":"2025-05-09 02:02","pubTimestamp":1746727354,"startTime":"0","endTime":"0","summary":"B of A Securities：维持Teva Pharmaceutical Indus(TEVA.US)评级，由买入调整至买入评级, 目标价由20.00美元调整至22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050902063394f0c43a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050902063394f0c43a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TEVA"],"gpt_icon":0},{"id":"1179206246","title":"异动解读 | 梯瓦制药盘中大涨9%，Q1业绩超预期且上调全年利润预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1179206246","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179206246?lang=zh_cn&edition=full","pubTime":"2025-05-08 00:40","pubTimestamp":1746636052,"startTime":"0","endTime":"0","summary":"周三盘中，梯瓦制药股价出现显著上涨，涨幅高达9.03%。这一强劲表现主要得益于公司发布的第一季度财报超出市场预期，并上调了全年利润指引。值得注意的是，梯瓦制药维持了全年16亿美元至19亿美元的自由现金流预期，这一稳健的现金流表现可能进一步增强了投资者的信心。此次财报和股价表现显示，市场对梯瓦制药的长期发展前景保持乐观态度。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TEVA"],"gpt_icon":0},{"id":"2533936500","title":"梯瓦制药盘中异动 早盘股价大涨5.27%报16.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533936500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533936500?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:32","pubTimestamp":1746624748,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时32分，梯瓦制药股票出现异动，股价大幅上涨5.27%。梯瓦制药股票所在的制药行业中，整体涨幅为0.39%。消息层面，截至21时32分，《梯瓦制药第一季度营收38.9亿美元，低于预期》资讯为影响梯瓦制药的重要信息。梯瓦制药预计全年调整后每股收益2.45美元至2.65美元。梯瓦制药预计全年调整后EBITDA 47亿美元至50亿美元，市场预估48.9亿美元，此前预计45亿美元至50亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213229a4756e6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213229a4756e6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4596","TEVA","BK4566","BK4007","BK4585","BK4559","BK4584","BK4557","BK4588"],"gpt_icon":0},{"id":"1141161737","title":"梯瓦制药一季度每股收益0.52美元，高于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1141161737","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141161737?lang=zh_cn&edition=full","pubTime":"2025-05-07 19:15","pubTimestamp":1746616531,"startTime":"0","endTime":"0","summary":"一季度销售额为38.9亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/d19c4352624941a040e41e8e153ad652","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/d19c4352624941a040e41e8e153ad652"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"梯瓦制药一季度每股收益0.52美元，高于预期","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA"],"gpt_icon":0},{"id":"2533986310","title":"梯瓦制药第一季度营收38.9亿美元，低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2533986310","media":"格隆汇","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533986310?lang=zh_cn&edition=full","pubTime":"2025-05-07 19:13","pubTimestamp":1746616414,"startTime":"0","endTime":"0","summary":"格隆汇5月7日｜梯瓦制药第一季度营收38.9亿美元，预估40亿美元。第一季度调整后每股收益0.52美元。梯瓦制药预计全年营收168亿美元至172亿美元，市场预估172.2亿美元，此前预计168亿美元至174亿美元。梯瓦制药预计全年调整后每股收益2.45美元至2.65美元。梯瓦制药仍然预测全年自由现金流16亿美元至19亿美元。梯瓦制药预计全年调整后EBITDA 47亿美元至50亿美元，市场预估48.9亿美元，此前预计45亿美元至50亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505071913459751dfd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505071913459751dfd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"梯瓦制药第一季度营收38.9亿美元，低于预期","news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TEVA"],"gpt_icon":0},{"id":"2518274873","title":"梯瓦制药盘中异动 急速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518274873?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:09","pubTimestamp":1741619345,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时09分，梯瓦制药股票出现波动，股价急速跳水5.01%。梯瓦制药股票所在的制药行业中，整体跌幅为1.97%。梯瓦制药公司简介：梯瓦制药工业有限公司总部位于以色列，是世界领先的仿制药制造商。梯瓦一半的销售额来自北美，在美国仿制药处方总数中所占的比例很高，为个位数。梯瓦还销售活性药物成分，提供合同制造服务，并拥有美国仿制药和特种药分销商Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230905abf32054&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230905abf32054&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4584","BK4559","BK4007","BK4557","BK4566","BK4596","TEVA","BK4588"],"gpt_icon":0},{"id":"2517216414","title":"B of A Securities：维持Teva Pharmaceutical Indus(TEVA.US)评级，由买入调整至买入评级, 目标价由23.00美元调整至20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517216414","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517216414?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:46","pubTimestamp":1741275975,"startTime":"0","endTime":"0","summary":"B of A Securities：维持Teva Pharmaceutical Indus(TEVA.US)评级，由买入调整至买入评级, 目标价由23.00美元调整至20.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06234648576704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TEVA"],"gpt_icon":0},{"id":"2514099391","title":"金十数据整理：每日美股市场要闻速递（2月25日 周二）","url":"https://stock-news.laohu8.com/highlight/detail?id=2514099391","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514099391?lang=zh_cn&edition=full","pubTime":"2025-02-25 21:08","pubTimestamp":1740488922,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["2NVD.UK","SNVD.UK","YY","BK4099","NVDY","NVD","NVD3.UK","NVDU","161631","IE0004086264.USD","NVDX","LU0820561909.HKD","03165","HD","ZM","NVIW.SI","TSLA","NVD2.UK","NVDL","SG9999002232.USD","TSYW.SI","LU2361044865.SGD","BIDU","LU2065171402.SGD","NVDS.UK","TSLL","ASML","RBLX","03347","3NVD.UK","NVDA","NBIS","TEVA","HK0000306701.USD","BK4513","LU0265550359.USD","NVDS","AI","LU0225283273.USD","0O59.UK","LU1720051017.SGD","LU0203201768.USD","SNY","159813","NVDD","API","SEC.AU","INTC","BK4505"],"gpt_icon":1},{"id":"2514803042","title":"赛诺菲(SNY.US)与梯瓦(TEVA.US)共同开发的duvakitug预计在下半年启动3期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2514803042","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514803042?lang=zh_cn&edition=full","pubTime":"2025-02-25 14:33","pubTimestamp":1740465193,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，赛诺菲与梯瓦日前公布了其共同开发的在研单抗duvakitug在2b期临床试验RELIEVE UCCD中获得的详细结果。新闻稿表示，这一结果展现了duvakitug成为“best-in-class”疗法的潜力。两家公司预计在今年下半年启动3期临床试验。2b期临床试验数据显示，接受duvakitug治疗的UC患者中，36%的低剂量组和48%高剂量组患者实现临床缓解，此数值在安慰剂组仅为20%。靶向TL1A有望缓解IBD患者的过度免疫反应。赛诺菲与梯瓦在2023年达成合作，共同开发并商业化duvakitug，用于治疗UC和CD。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK4584","SNY","BK4566","BK4585","BK1583","BK4588","BK1576","BK4557","BK4596","03347","BK4559","IE00BFXG1179.USD","BK4007","TEVA"],"gpt_icon":0},{"id":"2512481529","title":"梯瓦制药盘中异动 股价大涨5.01%报17.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512481529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512481529?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:04","pubTimestamp":1739981061,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时04分，梯瓦制药股票出现波动，股价大幅拉升5.01%。截至发稿，该股报17.40美元/股，成交量390.546万股，换手率0.34%，振幅4.53%。最近的财报数据显示，该股实现营业收入165.10亿美元，净利润-16.39亿美元，每股收益-1.45美元，毛利80.29亿美元，市盈率-11.97倍。梯瓦制药股票所在的制药行业中，整体涨幅为1.34%。梯瓦还销售活性药物成分，提供合同制造服务，并拥有美国仿制药和特种药分销商Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000421abd511a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000421abd511a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","BK4585","BK4566","BK4596","BK4557","TEVA","BK4588","BK4007","BK4559"],"gpt_icon":1},{"id":"2512165019","title":"梯瓦制药盘中异动 早盘股价大涨5.15%报17.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165019?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889124,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，梯瓦制药股票出现异动，股价快速拉升5.15%。截至发稿，该股报17.09美元/股，成交量84.8608万股，换手率0.07%，振幅0.49%。梯瓦制药股票所在的制药行业中，整体涨幅为0.82%。梯瓦一半的销售额来自北美，在美国仿制药处方总数中所占的比例很高，为个位数。梯瓦还销售活性药物成分，提供合同制造服务，并拥有美国仿制药和特种药分销商Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223204a24aacac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223204a24aacac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4584","BK4559","BK4007","BK4557","BK4566","BK4596","TEVA","BK4588"],"gpt_icon":0},{"id":"2509873255","title":"梯瓦制药2024财年实现净利润-16.39亿美元，同比减少193.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509873255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509873255?lang=zh_cn&edition=full","pubTime":"2025-02-07 09:00","pubTimestamp":1738890018,"startTime":"0","endTime":"0","summary":"2月7日，梯瓦制药公布财报，公告显示公司2024财年净利润为-16.39亿美元，同比减少193.20%；其中营业收入为165.10亿美元，同比增加4.18%，每股基本收益为-1.45美元。从资产负债表来看，梯瓦制药总负债336.06亿美元，其中短期债务18.68亿美元，资产负债比为1.18，流动比率为0.99。机构评级：截至2025年2月7日，当前有7家机构对梯瓦制药目标价做出预测，其中目标均价为24.71美元，其中最低目标价为21.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207090020abc5596e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207090020abc5596e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TEVA"],"gpt_icon":0},{"id":"2507674857","title":"梯瓦制药盘中异动 急速下跌5.04%报17.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507674857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507674857?lang=zh_cn&edition=full","pubTime":"2025-01-31 02:31","pubTimestamp":1738261868,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日02时31分，梯瓦制药股票出现异动，股价大幅下挫5.04%。截至发稿，该股报17.61美元/股，成交量2073.05万股，换手率1.83%，振幅5.23%。梯瓦制药股票所在的制药行业中，整体涨幅为1.58%。梯瓦一半的销售额来自北美，在美国仿制药处方总数中所占的比例很高，为个位数。梯瓦还销售活性药物成分，提供合同制造服务，并拥有美国仿制药和特种药分销商Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310231089876cbda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310231089876cbda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4596","BK4007","BK4566","BK4584","BK4559","BK4557","TEVA","BK4585"],"gpt_icon":0},{"id":"1150307862","title":"异动解读 | 梯瓦制药盘中股价暴跌11.75%,导致原因未明","url":"https://stock-news.laohu8.com/highlight/detail?id=1150307862","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150307862?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:49","pubTimestamp":1738162142,"startTime":"0","endTime":"0","summary":"梯瓦制药(TEVA)于2025年1月29日(周三)盘中股价暴跌11.75%,引发市场关注。\n\n然而,就目前公开的信息来看,针对导致这一暴跌的具体原因并没有任何相关新闻报道,暴跌原因仍然是个未解之谜。\n\n至于梯瓦制药本身的基本情况,它是全球领先的仿制药企业,在几个主要领域如中枢神经系统、呼吸系统、肿瘤等均有业务布局。不过其最新公布的财报显示净利润为负。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 梯瓦制药盘中股价暴跌11.75%,导致原因未明","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TEVA"],"gpt_icon":0},{"id":"2507272631","title":"梯瓦制药盘中异动 股价大跌10.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507272631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507272631?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:32","pubTimestamp":1738161128,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时32分，梯瓦制药股票出现波动，股价急速下挫10.73%。截至发稿，该股报19.22美元/股，成交量355.61万股，换手率0.31%，振幅3.48%。梯瓦制药股票所在的制药行业中，整体跌幅为0.01%。梯瓦一半的销售额来自北美，在美国仿制药处方总数中所占的比例很高，为个位数。梯瓦还销售活性药物成分，提供合同制造服务，并拥有美国仿制药和特种药分销商Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223208a2336741&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223208a2336741&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4566","BK4585","BK4584","BK4559","BK4596","TEVA","BK4588","BK4007","BK4557"],"gpt_icon":0},{"id":"1131450600","title":"Teva Pharmaceutical Indus 2024年第四季度调整后每股收益为$0.71，超过预期的$0.70，销售额为42亿美元，超过预期的41.3亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1131450600","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131450600?lang=zh_cn&edition=full","pubTime":"2025-01-29 20:04","pubTimestamp":1738152270,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Indus  公布了第四季度每股收益为$0.71，高于分析师普遍预期的$0.70，超出1.43个百分点。与去年同期销售额44.6亿美元相比下降了5.77%。以上内容来自Benzinga Earnings专栏，原文如下：Teva Pharmaceutical Indus  reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.70 by 1.43 percent. This is a 29 percent decrease over earnings of $1.00 per share from the same period last year.  The company reported quarterly sales of $4.20 billion which beat the analyst consensus estimate of $4.13 billion by 1.69 percent.  Th","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Teva Pharmaceutical Indus 2024年第四季度调整后每股收益为$0.71，超过预期的$0.70，销售额为42亿美元，超过预期的41.3亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA"],"gpt_icon":0},{"id":"2505712505","title":"梯瓦重磅偏头痛新药国内申报上市，百济神州EGFR降解剂1类新药在中国获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2505712505","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505712505?lang=zh_cn&edition=full","pubTime":"2025-01-22 18:36","pubTimestamp":1737542189,"startTime":"0","endTime":"0","summary":"2024 年 4 月，梯瓦公布了一项瑞玛奈珠单抗偏头痛预防性治疗的中国 III 期研究结果。主要目标是证明瑞玛奈珠单抗对患有偏头痛的中国成年受试者的疗效。结果显示，瑞玛奈珠单抗成功达到主要终点和所有次要终点，每月偏头痛天数显著减少，疗效表现优于安慰剂。百济神州EGFR降解剂1类新药在中国获批临床近日，中国国家药监局药品审评中心官网最新公示，百济神州1类新药BG-60366片获得临床试验默示许可，拟开发治疗EGFR突变型非小细胞肺癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122184558a22b7326&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122184558a22b7326&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","06160","TEVA","ONC","BK4139"],"gpt_icon":0},{"id":"2505762345","title":"梯瓦制药(TEVA.US)瑞玛奈珠单抗注射液在华申报上市 可显著改善患者偏头痛症状","url":"https://stock-news.laohu8.com/highlight/detail?id=2505762345","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505762345?lang=zh_cn&edition=full","pubTime":"2025-01-22 14:00","pubTimestamp":1737525629,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，1月22日，中国国家药监局药品审评中心官网最新公示，梯瓦制药申报的3.1类新药瑞玛奈珠单抗注射液上市申请已获得受理。该产品适用于成年患者偏头痛的预防性治疗。既往多项研究显示，瑞玛奈珠单抗可显著减少慢性偏头痛和发作性偏头痛患者的头痛天数，且安全性良好 。该研究评估了瑞玛奈珠单抗预防6~17岁儿童和青少年患者发作性偏头痛的有效性和安全性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1241682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"梯瓦制药(TEVA.US)瑞玛奈珠单抗注射液在华申报上市 可显著改善患者偏头痛症状","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4596","BK4559","BK4585","BK4557","BK4007","BK4588","BK4566","TEVA","BK4584"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tevapharm.com","stockEarnings":[{"period":"1week","weight":0.0958},{"period":"1month","weight":0.3343},{"period":"3month","weight":0.0826},{"period":"6month","weight":0.0602},{"period":"1year","weight":0.1052},{"period":"ytd","weight":-0.1851}],"compareEarnings":[{"period":"1week","weight":0.0346},{"period":"1month","weight":0.0919},{"period":"3month","weight":-0.0369},{"period":"6month","weight":-0.0238},{"period":"1year","weight":0.1193},{"period":"ytd","weight":-0.0053}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Teva Pharmaceutical Industries Limited于1944年2月13日在以色列注册成立。该公司是一家全球性制药公司，致力于帮助世界各地的患者获得负担得起的药物，并从改善健康的创新中受益。该公司的使命是成为仿制药、创新药和生物制药领域的全球领导者，改善患者的生活。该公司在全球开展业务，总部设在以色列，并在美国、欧洲和世界各地的许多其他市场都有重要业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.692308,"avgChangeRate":0.061256},{"month":2,"riseRate":0.384615,"avgChangeRate":-0.018156},{"month":3,"riseRate":0.461538,"avgChangeRate":-0.012141},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.005695},{"month":5,"riseRate":0.461538,"avgChangeRate":-0.000328},{"month":6,"riseRate":0.538462,"avgChangeRate":0.013933},{"month":7,"riseRate":0.615385,"avgChangeRate":0.035474},{"month":8,"riseRate":0.153846,"avgChangeRate":-0.065595},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.020432},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.021774},{"month":11,"riseRate":0.615385,"avgChangeRate":0.042634},{"month":12,"riseRate":0.538462,"avgChangeRate":0.019986}],"exchange":"NYSE","name":"梯瓦制药","nameEN":"Teva Pharmaceutical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"梯瓦制药(TEVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供梯瓦制药(TEVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"梯瓦制药,TEVA,梯瓦制药股票,梯瓦制药股票老虎,梯瓦制药股票老虎国际,梯瓦制药行情,梯瓦制药股票行情,梯瓦制药股价,梯瓦制药股市,梯瓦制药股票价格,梯瓦制药股票交易,梯瓦制药股票购买,梯瓦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"梯瓦制药(TEVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供梯瓦制药(TEVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}